MICRO-X LIMITED — Call Transcript 2025

Feb 10, 2025

INVESTOR CONFERENCE CALL –NEW DETAILS QUARTERLY RESULTS, STRATEGY & NEW STRATEGIC PARTNERSHIP

9.00am AEDT on 13 February 2025

Adelaide, Australia, 11 February 2025: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for health and security markets globally, advises that the Investor Conference Call has now been rescheduled as below.

The Company’s Chief Executive, Kingsley Hall will host an Investor Call at 9.00am AEDT on 13 February 2025 , to discuss the Company’s activities and results, the revised strategy, and the business outlook.

A recording of the call will be available on the Investor Centre section of the Company’s website for 60 days after the call.

Details to Pre-Register:

Direct Dial Details:

htps://s1.c-conf.com/diamondpass/100454233b7fgr5.html

Participants are encouraged to use the link above to preregister and obtain a unique PIN to access the call. A unique PIN will be provided for dialling into the call, which will provide immediate access to the event.

Conference ID: 100045423

Australian Toll Free : 1800 267 430 New Zealand callers : 0800 122 137 Other callers : +61 2 9008 9006

This ASX Announcement is authorised by the Company Secretary of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control emitters with this technology enables x-ray products with significant reduction in size, weight, and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security applications. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

Micro-X’s product portfolio spans a number of high margin, product applications in health and security. The first mobile digital radiology products are currently sold for diagnostic imaging in global healthcare, military and veterinary applications. The US Department of Homeland Security has contracted Micro-X to design a next-generation Airport security checkpoint. A miniature brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund. In November 2024, US Government agency ARPA-H contracted Micro-X to develop a full-body CT.

For more information visit: www.micro-x.com

Contacts

Micro-X Limited Investor Enquiries Kingsley Hall , Chief Executive Officer David Allen / John Granger Rebecca Puddy , Head of Corporate Communications Hawkesbury Partners Tel: +61 8 7099 3966 Tel: +61 2 9103 9494 Email: media@micro-x.com Email: dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Ltd. ABN 21 153 273 735, 1284 South Road, MAB Gate 2, Tonsley, South Australia 5042 www.micro-x.com